ArticlePharmaceuticals (Basel, Switzerland)2026
Scutellarein from
Chuchu Xi, Hongrong Fu, Xu Qin, Yujing Wang, Kerui Ren, Mengmeng Song, Huaduan Liang, Fang Zhao, Zhengyu Cao
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Chuchu XiJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Hongrong FuJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Xu QinJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Yujing WangJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Kerui RenJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Mengmeng SongJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Huaduan LiangJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.
Fang ZhaoDepartment of TCM Pharmacology, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Zhengyu CaoJiangsu Provincial Key Laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0002-2692-2949 Funding
Double First Class University Plan CPU2025CXY02Major Program of Jiangsu Provincial Administration for Market Regulation KJ2024014National Natural Science Foundation of China 82204653National Natural Science Foundation of China 82373929Tibet Autonomous Region Science and Technology Plan Project Key Project XZ202301ZY0014G
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
apoptosiscigarette smokeepithelial barrierlung injuryscutellarein
Identifiers
PMID41599711
PMCPMC12844651
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390